Phosphagenics Limited has appointed biotech industry veterans Mr. Lawrence Gozlan, Mr. Nathan Drona and Dr. Geert Cauwenbergh as non-executive directors, with Mr. Gozlan assuming the role of Chairman of the board on an interim basis. Mr. Stuart James, Dr. Sandra Webb, Mr. Don Clarke and Mr. Jonathan Addison have retired from the board. Mr. Lawrence Gozlan has been a leading fund manager and analyst in the Australian biotech sector over the past decade.

He is the Chief Investment Officer and founder of global investment fund Scientia Capital. Mr. Gozlan is currently a director of Oncosil Medical Ltd. and Prana Biotechnology Ltd. Mr. Nathan Drona joins the board following a 15 year career in international investment banking, most recently as Managing Director of Challiss in New York and Sydney. Dr. Geert Cauwenbergh is currently President and CEO of RXi Pharmaceuticals.